Chan et al. provided strong evidence that APN/CD13 activity was not absolutely required for enhanced migration by demonstrating that expression of a catalytically inactive form of APN/CD13 significantly enhanced the migration of lung adenocarcinoma cells [27]. The gene discussed is ANPEP; the disease is lung adenocarcinoma.